FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Merck | Vioxx | heart disease | lawsuits

Merck signals willingness to settle some Vioxx cases out of court

Tools

Faced with nearly 5,000 lawsuits filed over Vioxx, Merck has abandoned its decision to defend each and every one of the court actions, saying they'll settle some cases out of court if the plaintiff can show that the victim took Vioxx for a prolonged period and had no other risk factor for heart disease. The shift in legal strategy may prove a tricky one for the drug giant. Merck hoped to damp down the number of lawsuits by vowing to fight each one and may find itself encouraging more if it signals a willingness to settle. But after a Texas jury slammed Merck with a $253 million award in its first foray before a jury, plaintiffs may have all the encouragement they need.

- read this report from MarketWatch


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about Merck   Vioxx   heart disease   lawsuits